NCT00159094View on ClinicalTrials.gov

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2003

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Doxil and Vinorelbine

Trial Locations (2)

43055

RECRUITING

Hematology Oncology Consultants, Inc, Newark

43235

RECRUITING

Hematology Oncology Consultants, Inc, Columbus

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

Hematology Oncology Consultants

OTHER

NCT00159094 - A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter